Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 2
1970 1
1971 1
1975 2
1977 2
1980 1
1981 2
1983 2
1986 1
1990 1
2000 1
2010 1
2011 1
2012 1
2013 1
2014 1
2015 2
2016 1
2017 3
2018 3
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

27 results
Results by year
Filters applied: . Clear all
Page 1
Effect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck: The Active8 Randomized Clinical Trial.
Ferris RL, Saba NF, Gitlitz BJ, Haddad R, Sukari A, Neupane P, Morris JC, Misiukiewicz K, Bauman JE, Fenton M, Jimeno A, Adkins DR, Schneider CJ, Sacco AG, Shirai K, Bowles DW, Gibson M, Nwizu T, Gottardo R, Manjarrez KL, Dietsch GN, Bryan JK, Hershberg RM, Cohen EEW. Ferris RL, et al. Among authors: bryan jk. JAMA Oncol. 2018 Nov 1;4(11):1583-1588. doi: 10.1001/jamaoncol.2018.1888. JAMA Oncol. 2018. PMID: 29931076 Free PMC article. Clinical Trial.
An Evidence-Based Systematic Review of Goji (Lycium spp.) by the Natural Standard Research Collaboration.
Ulbricht C, Bryan JK, Costa D, Culwell S, Giese N, Isaac R, Nummy K, Pham T, Rapp C, Rusie E, Weissner W, Windsor RC, Woods J, Zhou S. Ulbricht C, et al. Among authors: bryan jk. J Diet Suppl. 2015 Jun;12(2):184-240. doi: 10.3109/19390211.2014.904128. Epub 2014 May 7. J Diet Suppl. 2015. PMID: 24806435 Review.
An evidence-based systematic review of active hexose correlated compound (AHCC) by the Natural Standard Research Collaboration.
Ulbricht C, Brigham A, Bryan JK, Catapang M, Chowdary D, Costa D, Culwell S, D'Auria D, Giese N, Iovin R, Isaac R, Juturu V, Liu A, Mintzer M, Rusie E, Shaffer M, Windsor RC. Ulbricht C, et al. Among authors: bryan jk. J Diet Suppl. 2013 Sep;10(3):264-308. doi: 10.3109/19390211.2013.822631. Epub 2013 Aug 9. J Diet Suppl. 2013. PMID: 23931762 Review.
An evidence-based systematic review of annatto (Bixa orellana L.) by the Natural Standard Research Collaboration.
Ulbricht C, Windsor RC, Brigham A, Bryan JK, Conquer J, Costa D, Giese N, Guilford J, Higdon ER, Holmes K, Isaac R, Jingst S, Kats J, Peery L, Rusie E, Savinainen A, Schoen T, Stock T, Tanguay-Colucci S, Weissner W. Ulbricht C, et al. Among authors: bryan jk. J Diet Suppl. 2012 Mar;9(1):57-77. doi: 10.3109/19390211.2012.653530. J Diet Suppl. 2012. PMID: 22432803 Review. No abstract available.
Prescription Drug Monitoring Programs and Pharmacist Orientation Toward Dispensing Controlled Substances.
Fendrich M, Bryan JK, Hooyer K. Fendrich M, et al. Among authors: bryan jk. Subst Use Misuse. 2018 Jul 3;53(8):1324-1330. doi: 10.1080/10826084.2017.1408650. Epub 2018 Jan 3. Subst Use Misuse. 2018. PMID: 29297725
An evidence-based systematic review of cinnamon (Cinnamomum spp.) by the Natural Standard Research Collaboration.
Ulbricht C, Seamon E, Windsor RC, Armbruester N, Bryan JK, Costa D, Giese N, Gruenwald J, Iovin R, Isaac R, Serrano JM, Tanguay-Colucci S, Weissner W, Yoon H, Zhang J. Ulbricht C, et al. Among authors: bryan jk. J Diet Suppl. 2011 Dec;8(4):378-454. doi: 10.3109/19390211.2011.627783. J Diet Suppl. 2011. PMID: 22432776 Review.
An evidence-based systematic review of amylase inhibitors by the Natural Standard Research Collaboration.
Ulbricht C, Bryan JK, Conquer J, Costa D, Stock T, Tanguay-Colucci S, Weissner W. Ulbricht C, et al. Among authors: bryan jk. J Diet Suppl. 2010 Mar;7(1):78-95. doi: 10.3109/19390210903535043. J Diet Suppl. 2010. PMID: 22435576 Review.
Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals.
Shayan G, Kansy BA, Gibson SP, Srivastava RM, Bryan JK, Bauman JE, Ohr J, Kim S, Duvvuri U, Clump DA, Heron DE, Johnson JT, Hershberg RM, Ferris RL. Shayan G, et al. Among authors: bryan jk. Clin Cancer Res. 2018 Jan 1;24(1):62-72. doi: 10.1158/1078-0432.CCR-17-0357. Epub 2017 Oct 23. Clin Cancer Res. 2018. PMID: 29061643 Free PMC article. Clinical Trial.
A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study.
Monk BJ, Brady MF, Aghajanian C, Lankes HA, Rizack T, Leach J, Fowler JM, Higgins R, Hanjani P, Morgan M, Edwards R, Bradley W, Kolevska T, Foukas P, Swisher EM, Anderson KS, Gottardo R, Bryan JK, Newkirk M, Manjarrez KL, Mannel RS, Hershberg RM, Coukos G. Monk BJ, et al. Among authors: bryan jk. Ann Oncol. 2017 May 1;28(5):996-1004. doi: 10.1093/annonc/mdx049. Ann Oncol. 2017. PMID: 28453702 Free PMC article. Clinical Trial.
Late-Stage Cancer Patients Remain Highly Responsive to Immune Activation by the Selective TLR8 Agonist Motolimod (VTX-2337).
Dietsch GN, Randall TD, Gottardo R, Northfelt DW, Ramanathan RK, Cohen PA, Manjarrez KL, Newkirk M, Bryan JK, Hershberg RM. Dietsch GN, et al. Among authors: bryan jk. Clin Cancer Res. 2015 Dec 15;21(24):5445-52. doi: 10.1158/1078-0432.CCR-15-0578. Epub 2015 Jul 7. Clin Cancer Res. 2015. PMID: 26152744 Free article. Clinical Trial.
27 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page